A few extra catalysts to add to my list up at the top. Shouldn’t be any shortage of positive newsflow. The FDA approval was the trigger, now things should really start moving quite steadily as we approach the initial 112 day readout
Ann: PAR Selects Advanced Clinical as CRO for Phase 3, page-12
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $116.8M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.5¢ | 29.5¢ | $56.35K | 188.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9339 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 14285 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PAR (ASX) Chart |